(Q31036824)

28 June 2017

title

Lipiodol transarterial chemoembolization for hepatocellular carcinoma: A systematic review of efficacy and safety data (English)

1 reference

28 June 2017

1 reference

hepatocellular carcinoma

1 reference

Riccardo Lencioni

1

1 reference

28 June 2017

Thierry de Baere

2

1 reference

28 June 2017

Michael C Soulen

3

1 reference

28 June 2017

William S Rilling

4

1 reference

28 June 2017

Jean-Francois H Geschwind

5

1 reference

28 June 2017

language of work or name

English

0 references

publication date

13 January 2016

1 reference

28 June 2017

1 reference

28 June 2017

volume

64

1 reference

28 June 2017

issue

1

1 reference

28 June 2017

page(s)

106-116

1 reference

Cancer mortality in the United Kingdom: projections to the year 2025.

28 June 2017

cites work

1 reference

Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression

21 January 2018

1 reference

The clinical management of hepatocellular carcinoma in the United States, Europe, and Asia: a comprehensive and evidence-based comparison and review.

21 January 2018

1 reference

GIDEON (Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib): second interim analysis

21 January 2018

1 reference

Loco-regional treatment of hepatocellular carcinoma

21 January 2018

1 reference

A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma

21 January 2018

1 reference

Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution.

21 January 2018

1 reference

Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

21 January 2018

1 reference

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

21 January 2018

1 reference

Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials.

21 January 2018

1 reference

Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival

21 January 2018

1 reference

Management of hepatocellular carcinoma: An update

21 January 2018

1 reference

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma

21 January 2018

1 reference

Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study

21 January 2018

1 reference

Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma

21 January 2018

1 reference

Practical methods for incorporating summary time-to-event data into meta-analysis

21 January 2018

1 reference

High-dose iodized oil transcatheter arterial chemoembolization for patients with large hepatocellular carcinoma

21 January 2018

1 reference

Ionic versus nonionic contrast media solvents used with an epirubicin-based agent for transarterial chemoembolization of hepatocellular carcinoma

21 January 2018

1 reference

A randomized controlled trial of transcatheter arterial chemoembolization with lipiodol, doxorubicin and cisplatin versus intravenous doxorubicin for patients with unresectable hepatocellular carcinoma

21 January 2018

1 reference

Transarterial chemoembolization plus or minus intravenous bevacizumab in the treatment of hepatocellular cancer: A pilot study

21 January 2018

1 reference

Transcatheter arterial chemoembolization of liver tumors: effects of embolization protocol on injectable volume of chemotherapy and subsequent arterial patency

21 January 2018

1 reference

Chemoembolization of hepatocellular carcinoma

21 January 2018

1 reference

Use of Lipiodol as a drug-delivery system for transcatheter arterial chemoembolization of hepatocellular carcinoma: a review

21 January 2018

1 reference

The Use of Transarterial Chemoembolization in the Treatment of Unresectable Hepatocellular Carcinoma: A Response to the Cochrane Collaboration Review of 2011

21 January 2018

1 reference

Chemoembolization for intermediate HCC: Is there proof of survival benefit?

21 January 2018

1 reference

Sorafenib in advanced hepatocellular carcinoma

21 January 2018

1 reference

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

Design and endpoints of clinical trials in hepatocellular carcinoma.

21 January 2018

1 reference

Hepatocellular Carcinoma: Consensus Recommendations of the National Cancer Institute Clinical Trials Planning Meeting

21 January 2018

1 reference

Prospective study of transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: an Asian cooperative study between Japan and Korea

21 January 2018

1 reference

Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma.

21 January 2018

1 reference

Transarterial chemotherapy alone versus transarterial chemoembolization for hepatocellular carcinoma: A randomized phase III trial

21 January 2018

1 reference

21 January 2018

Hepatocellular carcinoma

1 reference

Brivanib as adjuvant therapy to transarterial chemoembolization in patients with hepatocellular carcinoma: A randomized phase III trial

21 January 2018

1 reference

Hepatic arterial embolization in patients with unresectable hepatocellular carcinoma--a randomized controlled trial

21 January 2018

1 reference

7 January 2021

A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma

1 reference

7 January 2021

Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trial. Groupe CHC

1 reference

7 January 2021

Hepatocellular carcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up

1 reference

7 January 2021

Chemoembolization for hepatocellular carcinoma

1 reference

7 January 2021

Clinical evaluation of transcatheter arterial chemoembolization with 2-day-soluble gelatin sponge particles for hepatocellular carcinoma-comparison with insoluble gelatin sponge particles

1 reference

7 January 2021

Randomised controlled trial of lipiodol transarterial chemoembolisation with or without amiodarone for unresectable hepatocellular carcinoma

1 reference

7 January 2021

Roles played by chemolipiodolization and embolization in chemoembolization for hepatocellular carcinoma: single-blind, randomized trial

1 reference

7 January 2021

Circulatory alterations induced by intra-arterial injection of iodized oil and emulsions of iodized oil and doxorubicin: experimental study

1 reference

7 January 2021

Ultraselective transcatheter arterial chemoembolization with a 2-f tip microcatheter for small hepatocellular carcinomas: relationship between local tumor recurrence and visualization of the portal vein with iodized oil

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.28453

1 reference

28 June 2017

1 reference